Letter by Muller et al Regarding Article "Impact of COVID-19 on Patients Supported with a Left Ventricular Assist Device"
- PMID: 36066357
- DOI: 10.1097/MAT.0000000000001717
Letter by Muller et al Regarding Article "Impact of COVID-19 on Patients Supported with a Left Ventricular Assist Device"
Conflict of interest statement
Disclosure: Dr. van Laake received consultancy fees to University Medical Center Utrecht (UMCU) from Abbott, Medtronic, Vifor, Novartis. Dr. Oerlemans received consultancy fees from Abbott, Medtronic, Vifhor, Novartis, Pfizer, and Alnylam paid to the UMCU. The remaining authors have no conflicts of interest to report.
Comment in
-
Response to Muller et al. Regarding "Impact of COVID-19 on Patients Supported with a Left Ventricular Assist Device".ASAIO J. 2022 Sep 1;68(9):e157. doi: 10.1097/MAT.0000000000001718. Epub 2022 Aug 31. ASAIO J. 2022. PMID: 36066358 No abstract available.
Comment on
-
Impact of COVID-19 on Patients Supported with a Left Ventricular Assist Device.ASAIO J. 2021 Nov 1;67(11):1189-1195. doi: 10.1097/MAT.0000000000001578. ASAIO J. 2021. PMID: 34475334 Free PMC article.
References
Reference
-
- 1. Zakrzewski J, Coyle L, Aicher T, et al.: Impact of COVID-19 on patients supported with a left ventricular assist device. ASAIO J 67: 1189–1195, 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
